Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s12016-018-8675-2/fulltext.html
Reference55 articles.
1. Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, Atzeni F, Piccoli A, Todesco S (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119(8):700–706. https://doi.org/10.1016/j.amjmed.2005.11.034
2. Doria A, Gatto M, Zen M, Iaccarino L, Punzi L. Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 2014; 13(7):770–7, 777, DOI: https://doi.org/10.1016/j.autrev.2014.01.055
3. Doria A, Gatto M, Iaccarino L, Punzi L (2015) Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight. Lupus 24(4–5):507–515. https://doi.org/10.1177/0961203314559087
4. Gatto M, Kiss E, Naparstek Y, Doria A (2014) In-/off-label use of biologic therapy in systemic lupus erythematosus. BMC Med 12(1):30. https://doi.org/10.1186/1741-7015-12-30
5. Gatto M, Saccon F, Zen M, Bettio S, Iaccarino L, Punzi L, Doria A (2016) Success and failure of biological treatment in systemic lupus erythematosus: a critical analysis. J Autoimmun 74:94–105. https://doi.org/10.1016/j.jaut.2016.06.014
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development;Expert Opinion on Investigational Drugs;2024-07-09
2. Biologische Therapie bei systemischem Lupus erythematodes, Antiphospholipid-Syndrom und Sjögren-Syndrom: evidenz- und praxisbasierte Leitlinien;Kompass Autoimmun;2024
3. Tratamiento del lupus eritematoso sistémico: nuevas opciones terapéuticas;Revista Clínica Española;2023-12
4. Treatment of systemic lupus erythematosus: new therapeutic options;Revista Clínica Española (English Edition);2023-12
5. Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients;Medicina;2023-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3